This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mastropaolo, M. D.
Right arrow Articles by Melville, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mastropaolo, M. D.
Right arrow Articles by Melville, S. B.

 Previous Article  |  Next Article 

Infection and Immunity, September 2005, p. 6055-6063, Vol. 73, No. 9
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.9.6055-6063.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Synergy in Polymicrobial Infections in a Mouse Model of Type 2 Diabetes{dagger}

Matthew D. Mastropaolo,1 Nicholas P. Evans,2 Meghan K. Byrnes,2 Ann M. Stevens,1 John L. Robertson,2 and Stephen B. Melville1*

Department of Biological Sciences,1 Department of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, Virginia 24061-04062

Received 23 February 2005/ Returned for modification 1 April 2005/ Accepted 22 April 2005

Human diabetics frequently suffer delayed wound healing, increased susceptibility to localized and systemic infections, and limb amputations as a consequence of the disease. Lower-limb infections in diabetic patients are most often polymicrobial, involving mixtures of aerobic, facultative anaerobic, and anaerobic bacteria. The purpose of this study is to determine if these organisms contribute to synergy in polymicrobial infections by using diabetic mice as an in vivo model. The model was the obese diabetic mouse strain BKS.Cg-m +/+ Leprdb/J, a model of human type 2 diabetes. Young (5- to 6-week-old) prediabetic mice and aged (23- to 24-week-old) diabetic mice were compared. The mice were injected subcutaneously with mixed cultures containing Escherichia coli, Bacteroides fragilis, and Clostridium perfringens. Progression of the infection (usually abscess formation) was monitored by examining mice for bacterial populations and numbers of white blood cells at 1, 8, and 22 days postinfection. Synergy in the mixed infections was defined as a statistically significant increase in the number of bacteria at the site of injection when coinfected with a second bacterium, compared to when the bacterium was inoculated alone. E. coli provided strong synergy to B. fragilis but not to C. perfringens. C. perfringens and B. fragilis provided moderate synergy to each other but only in young mice. B. fragilis was anergistic (antagonistic) to E. coli in coinfections in young mice at 22 days postinfection. When age-matched nondiabetic mice (C57BLKS/J) were used as controls, the diabetic mice exhibited 5 to 35 times the number of CFU as did the nondiabetic mice, indicating that diabetes was a significant factor in the severity of the polymicrobial infections.


* Corresponding author. Mailing address: Department of Biological Sciences, Virginia Tech, 2119 Derring Hall, Blacksburg, VA 24061-0406. Phone: (540) 231-1441. Fax: (540) 231-9307. E-mail: melville{at}vt.edu.

{dagger} Supplemental material for this article may be found at http://iai.asm.org/.

Editor: D. L. Burns


Infection and Immunity, September 2005, p. 6055-6063, Vol. 73, No. 9
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.9.6055-6063.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Kesavalu, L., Sathishkumar, S., Bakthavatchalu, V., Matthews, C., Dawson, D., Steffen, M., Ebersole, J. L. (2007). Rat Model of Polymicrobial Infection, Immunity, and Alveolar Bone Resorption in Periodontal Disease. Infect. Immun. 75: 1704-1712 [Abstract] [Full Text]